Skip to main content
. 2023 Feb 10;28(4):341–350. doi: 10.1093/oncolo/oyac251

Figure 1.

Figure 1.

CONSORT Diagram of the study depicting screened and eligible populations, reasons for exclusion, and break down of patients into the NAFLD/NASH and other etiologies cohorts.